Acute mastoiditis: A 10-year retrospective study at a tertiary care center

Michal Bartos1, Milan Urik1, Vit Kruntorad1

  • 1Department of Pediatric Otorhinolaryngology, University Hospital Brno, Brno, Czech Republic; Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Insights

The COVID-19 pandemic increased acute mastoiditis (AM) incidence and severity in children, leading to more surgeries. Streptococcus pneumoniae was a common pathogen, highlighting the need for vigilant monitoring and early intervention.

Area of Science:

  • Pediatric Otolaryngology
  • Infectious Diseases Epidemiology

Background:

  • Acute mastoiditis (AM) is a severe complication of acute otitis media (AOM) in children.
  • Evidence suggests the COVID-19 pandemic may have altered AM's epidemiology and severity.

Purpose of the Study:

  • To analyze changes in pediatric acute mastoiditis (AM) incidence, severity, and management.
  • To compare AM cases pre- and post-COVID-19 pandemic.

Main Methods:

  • Retrospective cohort study of pediatric patients (0-18 years) diagnosed with AM from 2015-2024.
  • Analysis of demographic data, clinical presentation, imaging, surgical interventions, complications, bacteriology, and antimicrobial therapy.
  • Comparison of outcomes between pre-COVID (2015-2019) and pandemic/post-COVID (2020-2024) periods.

Main Results:

  • AM cases increased post-pandemic (41 vs. 64).
  • Higher rates of HRCT use and mastoidectomy (AMTs) were observed during the pandemic/post-COVID period (24 vs. 38).
  • Intra- and extracranial complications rose significantly (2 vs. 10), with increased isolation of Streptococcus pneumoniae.

Conclusions:

  • The pandemic/post-COVID era saw increased pediatric AM incidence and severity, necessitating more surgical interventions.
  • Elevated pneumococcal infections and reduced prehospital antibiotic use may contribute to advanced disease.
  • Ongoing surveillance of pathogens and prompt management are crucial for reducing AM complications.
Abstract